[go: up one dir, main page]

GB0009037D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0009037D0
GB0009037D0 GBGB0009037.3A GB0009037A GB0009037D0 GB 0009037 D0 GB0009037 D0 GB 0009037D0 GB 0009037 A GB0009037 A GB 0009037A GB 0009037 D0 GB0009037 D0 GB 0009037D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0009037.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0009037.3A priority Critical patent/GB0009037D0/en
Publication of GB0009037D0 publication Critical patent/GB0009037D0/en
Priority to PCT/EP2001/004203 priority patent/WO2001078726A1/en
Priority to AU2001258330A priority patent/AU2001258330A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0009037.3A 2000-04-13 2000-04-13 Organic compounds Ceased GB0009037D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0009037.3A GB0009037D0 (en) 2000-04-13 2000-04-13 Organic compounds
PCT/EP2001/004203 WO2001078726A1 (en) 2000-04-13 2001-04-11 New uses of imidazolylmethyl-pyridines
AU2001258330A AU2001258330A1 (en) 2000-04-13 2001-04-11 New uses of imidazolylmethyl-pyridines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0009037.3A GB0009037D0 (en) 2000-04-13 2000-04-13 Organic compounds

Publications (1)

Publication Number Publication Date
GB0009037D0 true GB0009037D0 (en) 2000-05-31

Family

ID=9889785

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0009037.3A Ceased GB0009037D0 (en) 2000-04-13 2000-04-13 Organic compounds

Country Status (3)

Country Link
AU (1) AU2001258330A1 (en)
GB (1) GB0009037D0 (en)
WO (1) WO2001078726A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10352510A1 (en) * 2003-11-07 2005-06-23 Forschungsinstitut Für Die Biologie Landwirtschaftlicher Nutztiere Method for identifying active ingredients for influencing body mass and fat intake
ES2388876T3 (en) 2005-07-29 2012-10-19 Vanda Pharmaceuticals Inc. Use of [2- (2-methylimidazol-1-yl) methyl] pyridine for the treatment of sleep disorders
WO2009097414A1 (en) * 2008-01-29 2009-08-06 Vanda Pharmaceuticals, Inc. Use of imidazolylalkyl-pyridines for the treatment of addictive disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2028317B (en) * 1978-08-15 1982-11-10 Pfizer Ltd 2-(imidazol-1-ylmethyl)-pyridine and -quinoline thromboxane synthetase inhibitors
DE4131584A1 (en) * 1991-09-23 1993-03-25 Sandoz Ag IMIDAZOLYLMETHYL-PYRIDINE, THEIR PRODUCTION AND USE AS A PHARMACEUTICAL
ATE375332T1 (en) * 1998-12-24 2007-10-15 Astellas Pharma Inc IMIDAZOLE COMPOUNDS AND THEIR MEDICAL USES

Also Published As

Publication number Publication date
AU2001258330A1 (en) 2001-10-30
WO2001078726A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
AU8389101A (en) Organic compounds
GB0010955D0 (en) Organic compounds
GB0006398D0 (en) Organic compounds
GB0003111D0 (en) Organic compounds
GB0008694D0 (en) Organic compounds
GB0001448D0 (en) Organic compounds
GB0008785D0 (en) Organic compounds
GB0002100D0 (en) Organic compounds
GB0007108D0 (en) Organic compounds
GB0007911D0 (en) Organic compounds
GB0002740D0 (en) Organic compounds
GB0009037D0 (en) Organic compounds
GB0009054D0 (en) Organic compounds
GB0009055D0 (en) Organic compounds
GB0010200D0 (en) Organic compounds
GB0009053D0 (en) Organic compounds
GB0010210D0 (en) Organic compounds
GB0006735D0 (en) Organic compounds
GB0010201D0 (en) Organic compounds
GB0001702D0 (en) Organic compounds
GB0009899D0 (en) Organic compounds
GB0009593D0 (en) Organic compounds
GB0010204D0 (en) Organic compounds
GB0010205D0 (en) Organic compounds
GB0010206D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)